The use of medication against attention deficit/hyperactivity disorder in Denmark: a drug use study from a patient perspective. - Test2 - elhamkhani - TriplyDB

The use of medication against attention deficit/hyperactivity disorder in Denmark: a drug use study from a patient perspective.

The use of medication against attention deficit/hyperactivity disorder in Denmark: a drug use study from a patient perspective.

http://www.wikidata.org/entity/Q38027452

about

Factors affecting treatment adherence to atomoxetine in ADHD: a systematic review Adherence, persistence, and medication discontinuation in patients with attention-deficit/hyperactivity disorder - a systematic literature review Initiation and Persistence of Pharmacotherapy for Youths with Attention Deficit Hyperactivity Disorder in Taiwan The Effect of Medical Treatment of Attention Deficit Hyperactivity Disorder (ADHD) on Foster Care Caseloads: Evidence from Danish Registry Data.Children's relative age in class and use of medication for ADHD: a Danish Nationwide Study Adverse pregnancy outcomes after exposure to methylphenidate or atomoxetine during pregnancy Factors that Affect the Adherence to ADHD Medications during a Treatment Continuation Period in Children and Adolescents: A Nationwide Retrospective Cohort Study Using Korean Health Insurance Data from 2007 to 2011 Medical treatment of children and youths with attention-deficit/hyperactivity disorder (ADHD): a Norwegian Prescription Registry Based Study Differences in Utilization Patterns among Medications in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: a 36-Month Retrospective Study Using the Korean Health Insurance Review and Assessment Claims Database.Concomitant pharmacotherapy of psychotropic medications in EU children and adolescents with attention-deficit/hyperactivity disorder.Prescribing patterns for attention deficit hyperactivity disorder medications among children and adolescents in Korea, 2007-2011.Use of SSRIs among Danish children: a nationwide study.Early discontinuation of attention-deficit/hyperactivity disorder drug treatment: a Danish nationwide drug utilization study.Deviant patterns of methylphenidate use in adults: a Danish nationwide registry-based drug utilization study.A nationwide study of attention-deficit/hyperactivity disorder drug use among adults in Iceland 2003-2012.Safety and Tolerability of Lisdexamfetamine: A Retrospective Cohort Study.Off-label prescribing of psychotropic drugs in a Danish child and adolescent psychiatric outpatient clinic.Combined methylphenidate and atomoxetine pharmacotherapy in attention deficit hyperactivity disorder.Use of attention-deficit/hyperactivity disorder medication among older adults in Denmark.Patterns and profiles of Methylphenidate use in both children and adults.Estimated prevalence and incidence of diagnosed ADHD and health care utilization in adults in Sweden - a longitudinal population-based register study.

P2860

Q26746236-3DF75EED-C331-4BBE-A3DE-306E806D8DD4 Q26859455-AFAC09DA-4167-4B79-80FF-9FE684940E29 Q28553475-1FD22529-9A67-498F-BF53-5C7C05E58444 Q30985194-5151EBF2-D78F-4115-896B-074CF1F5B669 Q34776232-63743BBE-0F2C-46E7-8318-122AE2C78149 Q35049056-8112C316-CA5A-4C71-B608-4E600A1E2C3E Q36317152-BEFCEF6A-6AEE-41FD-A399-FE1A083CCCFE Q36780303-EE92E8BB-ECDA-4137-B029-90FDF680D9E1 Q37110515-56B2C855-D421-4961-9A44-534B3FDCBE7A Q37365301-F3F9971E-27D7-4A7C-AEBD-00B63C1C1EC7 Q37525872-03C0DEBC-63D3-4A45-9613-754C2E8615CD Q38184948-D57B1A0B-EAF1-4EB8-B045-9CA9B57CE0EA Q38418781-11A6CCDA-D0A6-41FF-9102-09431F8243A7 Q40638080-C17DF706-B03E-49AB-B7AE-C1C72E141FCA Q46622605-35C79179-2872-48C8-BC2E-D9E8E4AA63B3 Q48194563-A7A15602-4E3A-42E7-8488-C1F33D52959D Q50565390-8E56F968-23FF-41D7-B497-22A64C3093F7 Q50576718-91116AEC-16A8-4519-96E9-8EF7740B349F Q50578046-ECB05D2B-A3F9-4914-924B-C7318FC93839 Q51411756-83B42C9D-A0CA-4F61-A1A0-47383B0C3B1D Q55399341-49FFA577-6C99-4F2C-A605-7D90500CA9FB

P2860

The use of medication against attention deficit/hyperactivity disorder in Denmark: a drug use study from a patient perspective.

http://www.wikidata.org/entity/Q38027452

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

The use of medication against ...... dy from a patient perspective.

@en

type

label

The use of medication against ...... dy from a patient perspective.

@en

prefLabel

The use of medication against ...... dy from a patient perspective.

@en

P1433

Q38027452-26013845-12EB-4BD5-9C58-B72A936B8A53

P1476

Q38027452-90C4E6E5-E7EC-4F20-B7E3-A406A04719EB

P2093

Q38027452-5DA8A382-62EA-4D45-B284-63005BA4A41D

Q38027452-8CD1EFF9-EBEF-4148-B6CE-38EF7CD6FF10

Q38027452-D317AEAA-A487-4B0F-B4BD-EC8FCC6C5A00

P2860

Q38027452-024B4BC9-2DFE-42B3-BFDA-CE39CA97A9FE

Q38027452-14563657-2848-4EC6-9D35-3980697A095A

Q38027452-1BB65F2C-9017-44A5-979C-1096B6B39161

Q38027452-1EAEA981-790B-4BED-87B6-9AFF54FFE1BC

Q38027452-28053919-13ED-47A9-96CB-2321C8E23437

Q38027452-2D3C964D-A77F-40D6-AF67-832D6107A324

Q38027452-334255F6-2551-4DF0-A3EA-71FDD589751D

Q38027452-38A5F24D-9003-4293-A9C2-44FA7A4CFE4E

Q38027452-3DD1F969-009E-4C08-B950-2D1C815657CF

Q38027452-3EAF864B-6AF0-4184-8885-E739BB25C92A

P2888

Q38027452-7B2C4843-6526-4620-A1F6-6EFB4B5C674D

P304

Q38027452-A00B055F-824D-4ACC-9763-2B6E79707389

P31

Q38027452-57AC65AA-B5F4-41CA-B171-7503367BFC36

P356

Q38027452-F7074109-9A65-43A3-A857-5E44AA8CE4CE

P433

Q38027452-5A3861B2-2E4B-434F-974E-DEC63D1700FB

P478

Q38027452-4F84227E-7972-49F2-9186-3F9C4C33D37A

P50

Q38027452-09CA9B11-73ED-4693-93DC-C4AD980818DB

Q38027452-4EE2DC04-A204-4A44-BBF2-E8F113629587

Q38027452-A2D6A548-7128-4982-8763-BAAB732A6CC8

P577

Q38027452-B59503EE-9945-4F04-BADA-F67404F85061

P5875

Q38027452-C070B0B6-344B-47A0-96FB-51FEBEE8F77A

P6179

Q38027452-CA90EA32-6CAF-4683-B072-6279B1BA6201

P698

Q38027452-9C017A2A-2D24-494B-9BFD-39B844BFDC5D

P921

Q38027452-0A65E827-AFC2-4EC1-9CAF-8CB7063E3CCA

Q38027452-B3E952BC-7D6A-4103-89C5-24BB3E42D640

P356

S00228-012-1344-0

P1433

European Journal of Clinical Pharmacology

P1476

The use of medication against ...... dy from a patient perspective.

@en

P2093

Bine Kjøller Bjerregaard

http://www.w3.org/2001/XMLSchema#string

Lisbeth Sandal Kortegaard

http://www.w3.org/2001/XMLSchema#string

Søren Ilsøe Moreno

http://www.w3.org/2001/XMLSchema#string

P2860

Efficacy and Safety Limitations of Attention-Deficit Hyperactivity Disorder Pharmacotherapy in Children and Adults

Practice Parameter for the Assessment and Treatment of Children and Adolescents With Attention-Deficit/Hyperactivity Disorder

Assessment of pharmacokinetics and pharmacodynamic effects related to abuse potential of a unique oral osmotic-controlled extended-release methylphenidate formulation in humans.

Behavioral sensitization and cross-sensitization between methylphenidate amphetamine, and 3,4-methylenedioxymethamphetamine (MDMA) in female SD rats.

The meaning of attention-deficit/hyperactivity disorder medication and parents' initiation and continuity of treatment for their child

Does stimulant therapy of attention-deficit/hyperactivity disorder beget later substance abuse? A meta-analytic review of the literature.

Methylphenidate for the treatment of depressive symptoms, including fatigue and apathy, in medically ill older adults and terminally ill adults.

National trends in psychotropic medication polypharmacy in office-based psychiatry.

National trends in child and adolescent psychotropic polypharmacy in office-based practice, 1996-2007

Age of methylphenidate treatment initiation in children with ADHD and later substance abuse: prospective follow-up into adulthood

P2888

s00228-012-1344-0

P304

589-598

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00228-012-1344-0

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

69

http://www.w3.org/2001/XMLSchema#string

P50

Dorte Glintborg

Anton Pottegård

P577

2012-07-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

229326562

http://www.w3.org/2001/XMLSchema#string

P6179

1020840284

http://www.w3.org/2001/XMLSchema#string

P698

22811260

http://www.w3.org/2001/XMLSchema#string

P921